2348 Dawnrays Pharmaceutical Holdings Ltd. HKEX · Hong Kong

Dawnrays Pharmaceutical Holdings (2348) news

Dawnrays Pharmaceutical Holdings Ltd. is a public biotech or pharmaceutical company listed on HKEX under the ticker 2348, recorded under Hong Kong. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Dawnrays Pharmaceutical Holdings news

We have not published a story on Dawnrays Pharmaceutical Holdings yet. When there is news, it will appear here.

Questions about Dawnrays Pharmaceutical Holdings

What is the ticker symbol of Dawnrays Pharmaceutical Holdings?

Dawnrays Pharmaceutical Holdings Ltd. trades under the ticker 2348 on HKEX.

Where is Dawnrays Pharmaceutical Holdings listed?

Dawnrays Pharmaceutical Holdings Ltd. is listed on HKEX.

Which country or territory is Dawnrays Pharmaceutical Holdings listed under?

Our directory records Dawnrays Pharmaceutical Holdings Ltd. under Hong Kong.

What does Dawnrays Pharmaceutical Holdings do?

Our directory classifies Dawnrays Pharmaceutical Holdings Ltd. as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.

What is the ISIN of Dawnrays Pharmaceutical Holdings?

The ISIN recorded for Dawnrays Pharmaceutical Holdings Ltd. is KYG2687M1006.

Does aibio.space cover Dawnrays Pharmaceutical Holdings?

aibio.space lists Dawnrays Pharmaceutical Holdings Ltd. among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Dawnrays Pharmaceutical Holdings?

Companies in our directory listed in the same country and business area as Dawnrays Pharmaceutical Holdings: Extrawell Pharmaceutical Holdings, Sino Biopharmaceutical, HUTCHMED (China), Grand Pharmaceutical Group, InSilico Medicine Cayman TopCo, China Resources Pharmaceutical Group.

Investor discussion: Dawnrays Pharmaceutical Holdings

Members talk about Dawnrays Pharmaceutical Holdings (2348). Reader posts, not aibio.space reporting, and not investment advice.

Rules

Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
Say whether you hold the stock. Every post states long, short or no position.
No paid or sponsored posts. Do not post for anyone who pays or rewards you.
No buy or sell calls and no price targets.
No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Capital-markets timeline

Financings, listing notices, splits, legal actions and other investor events at Dawnrays Pharmaceutical Holdings, newest first. Each line links the filing it comes from.

Jun 18, 2026Mergers
Transaction under the Listing Rules: DISCLOSEABLE TRANSACTION - INVESTMENT IN A LIMITED PARTNERSHIP. Source
Apr 23, 2026Financings
Share or debt issue: PROPOSALS FOR GENERAL MANDATES TO ISSUE AND REPURCHASE SHARES; RE-ELECTION OF DIRECTORS AND NOTICE OF ANNUAL GENERAL MEETING. Source
Apr 23, 2025Financings
Share or debt issue: PROPOSALS FOR GENERAL MANDATES TO ISSUE AND REPURCHASE SHARES; RE-ELECTION OF DIRECTORS AND NOTICE OF ANNUAL GENERAL MEETING. Source

Press releases

Headlines of Dawnrays Pharmaceutical Holdings's own announcements, newest first. Each opens the full release on the newswire that carried it.

Sep 17, 2026HKEXnews
NOTIFICATION LETTER AND REQUEST FORM TO NON-REGISTERED HOLDER - NOTICE OF PUBLICATION OF 2026 INTERIM REPORT
Sep 17, 2026HKEXnews
NOTIFICATION LETTER AND REPLY FORM TO REGISTERED SHAREHOLDERS - NOTICE OF PUBLICATION OF 2026 INTERIM REPORT
Aug 28, 2026HKEXnews
INTERIM DIVIDEND FOR THE SIX MONTHS ENDED 30 JUNE 2026 AND CLOSURE OF REGISTER OF MEMBERS
Aug 28, 2026HKEXnews
ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2026
Jul 3, 2026HKEXnews
GRANT OF SHARE OPTIONS
Jun 18, 2026HKEXnews
DISCLOSEABLE TRANSACTION - INVESTMENT IN A LIMITED PARTNERSHIP
May 29, 2026HKEXnews
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
May 22, 2026HKEXnews
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 22 MAY 2026
Apr 23, 2026HKEXnews
NOTIFICATION LETTER AND REQUEST FORM TO NON-REGISTERED HOLDER - NOTICE OF PUBLICATION OF 2025 ANNUAL REPORT, CIRCULAR, NOTICE OF ANNUAL GENERAL MEETING, PROXY FORM AND 2025 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT
Apr 23, 2026HKEXnews
NOTIFICATION LETTER AND REPLY FORM TO REGISTERED SHAREHOLDERS - NOTICE OF PUBLICATION OF 2025 ANNUAL REPORT, CIRCULAR, NOTICE OF ANNUAL GENERAL MEETING, PROXY FORM AND 2025 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT
Apr 23, 2026HKEXnews
NOTICE OF ANNUAL GENERAL MEETING
Apr 23, 2026HKEXnews
PROPOSALS FOR GENERAL MANDATES TO ISSUE AND REPURCHASE SHARES; RE-ELECTION OF DIRECTORS AND NOTICE OF ANNUAL GENERAL MEETING
Mar 27, 2026HKEXnews
FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2025 AND CLOSURE OF REGISTER OF MEMBERS
Mar 27, 2026HKEXnews
ANNOUNCEMENT OF THE ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2025
Sep 11, 2025HKEXnews
NOTIFICATION LETTER AND REQUEST FORM TO NON-REGISTERED HOLDER - NOTICE OF PUBLICATION OF 2025 INTERIM REPORT
Sep 11, 2025HKEXnews
NOTIFICATION LETTER AND REPLY FORM TO REGISTERED SHAREHOLDERS - NOTICE OF PUBLICATION OF 2025 INTERIM REPORT
Aug 22, 2025HKEXnews
INTERIM DIVIDEND FOR THE SIX MONTHS ENDED 30 JUNE 2025 AND CLOSURE OF REGISTER OF MEMBERS
Aug 22, 2025HKEXnews
ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2025
Jul 31, 2025HKEXnews
APPOINTMENT OF NON-EXECUTIVE DIRECTOR
Jul 11, 2025HKEXnews
Terms of Reference for Nomination Committee

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open HKEX:2348 on TradingView.

Listing details

Company: Dawnrays Pharmaceutical Holdings Ltd.
Ticker: 2348
Listing: HKEX
Country or territory: Hong Kong
Business scope: Pharmaceuticals: Major
ISIN: KYG2687M1006
Last quote in directory: 2026-10-22
Directory source: Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction